EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know - The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make up approximately 90% of India’s pharma exports to the US — were explicitly exempted from the levy. This article breaks down what the new tariff […]
CDSCO Launches Major Overhaul: Outsourcing GMP Audits and Building 1500-Expert Scientific Cadre - India’s Central Drugs Standard Control Organisation (CDSCO) is embarking on the most significant regulatory restructuring in its history. In a move designed to strengthen pharmaceutical quality oversight and align with global regulatory standards, CDSCO will begin outsourcing Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) audits to external accredited agencies, while simultaneously building a […]
India Supplies 20% of Global Generic Medicines, GTRI Confirms IP Rules WTO-Compliant - New Delhi, May 2026 — India now supplies nearly 20% of the world’s generic medicines, according to a comprehensive report from the Global Trade Research Initiative (GTRI). The report, released in early May 2026, also affirms that India’s intellectual property (IP) regime remains fully compliant with World Trade Organization (WTO) standards, pushing back against persistent […]
India’s Generic Drug Resilience: 20% Global Market Share, US Tariff Exemption, and the Semaglutide Revolution - India’s pharmaceutical industry continues to demonstrate remarkable resilience and global influence in 2026. With the nation supplying approximately 20% of the world’s generic medicines, recent developments — including US tariff exemptions on generics, the post-patent semaglutide boom, and India’s WTO-compliant intellectual property framework — are reshaping the global pharmaceutical landscape. This article provides a comprehensive […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us